Latest news with #Strattera
Time Business News
3 days ago
- Health
- Time Business News
When to Choose Strattera Over Adderall
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions of people worldwide, leading to difficulties with focus, impulsivity, and hyperactivity. While stimulant medications like Adderall are often the first line of treatment, non-stimulant options such as Strattera (atomoxetine) can be a more appropriate choice in certain situations. Understanding when to choose strattera vs adderall involves evaluating factors such as the patient's medical history, potential side effects, risk of substance abuse, and overall treatment goals. When managing depression and anxiety, selecting the appropriate medication is crucial for effective treatment. Both medications in question are popular SSRIs that help balance serotonin levels in the brain, improving mood and emotional stability. In the middle of this discussion, Lexapro vs zoloft often arises as a common comparison due to their similar uses but distinct side effect profiles and dosing schedules. While some patients respond better to one, others may experience fewer adverse effects or more rapid relief with the alternative. Consulting a healthcare provider is essential to tailor the choice to individual needs and medical history. Strattera and Adderall are both approved by the FDA for treating ADHD but function in very different ways. Adderall is a stimulant composed of amphetamine salts that work by increasing the levels of dopamine and norepinephrine in the brain. This results in improved attention, reduced impulsivity, and greater overall concentration. On the other hand, Strattera is a selective norepinephrine reuptake inhibitor (NRI), which means it primarily boosts norepinephrine without significantly impacting dopamine levels. Unlike Adderall, Strattera is not a controlled substance and carries a much lower risk of abuse. One of the primary reasons to choose Strattera over Adderall is when there's a concern about substance misuse or a history of addiction. Adderall is a Schedule II controlled substance due to its high potential for abuse and dependency. For individuals with a history of substance use disorder, Adderall may pose a serious risk. Strattera, being non-stimulant and non-addictive, offers a safer alternative. It allows for effective ADHD management without the risk of reinforcing addictive behaviors, making it particularly useful in populations vulnerable to stimulant misuse. Many individuals with ADHD also suffer from comorbid mental health conditions like anxiety or depression. In such cases, Strattera may be a better option than Adderall. Stimulants like Adderall can exacerbate anxiety symptoms in some patients, leading to increased restlessness, jitteriness, or panic attacks. Strattera, on the other hand, has shown some efficacy in improving symptoms of anxiety and may also provide mild antidepressant effects due to its norepinephrine-enhancing properties. Choosing Strattera can help manage both ADHD and accompanying mood or anxiety disorders without worsening either condition. Adderall, especially the immediate-release version, has a relatively short duration of action, requiring multiple doses throughout the day. Even the extended-release versions may wear off by late afternoon or evening. In contrast, Strattera is taken once daily and offers 24-hour symptom coverage. This can be particularly advantageous for individuals who need consistent control over their ADHD symptoms throughout the day and into the evening. Students, working professionals, or parents managing multiple responsibilities might find this steady effect preferable to the peaks and troughs associated with stimulant medications. While stimulants are effective for many people, they also come with a host of potential side effects, including insomnia, appetite suppression, irritability, increased heart rate, and elevated blood pressure. For some individuals, these side effects can be intolerable or even dangerous, particularly if they have underlying cardiovascular issues. Strattera generally has a milder side effect profile and is not associated with the same degree of appetite suppression or cardiovascular stimulation. Although it has its own set of side effects, such as nausea or fatigue, these are often more manageable and tend to lessen over time. In some clinical scenarios, a non-stimulant medication like Strattera is the preferred first-line treatment. For example, in younger children (especially those under six years of age), stimulants may not be recommended due to potential side effects and lack of data on long-term safety. Pediatricians may opt for Strattera as a gentler initial approach. Additionally, parents who are concerned about the stigma or potential long-term effects of stimulant use may feel more comfortable starting their child on a non-stimulant option. Stimulants such as Adderall can interfere with sleep, especially if taken later in the day. Sleep disturbances are a common complaint among stimulant users and can contribute to irritability, mood swings, and worsening of ADHD symptoms. Strattera is less likely to cause sleep disruption and may even help improve sleep quality for some patients. For individuals who already struggle with insomnia or erratic sleep patterns, Strattera may be the better treatment choice. One of the key differences between Adderall and Strattera is how quickly they take effect. Adderall typically produces noticeable results within hours, making it ideal for patients seeking immediate symptom relief. Strattera, however, requires several days to weeks to build up in the system and reach full therapeutic effect. For patients and clinicians willing to adopt a slower, more gradual treatment approach, this delayed onset can be worthwhile, especially given Strattera's longer-term stability and lower side effect profile. Because Adderall is a controlled substance, it comes with regulatory burdens such as limited refills, stricter prescribing rules, and potential stigma. Some patients or caregivers may prefer a treatment that does not involve these complications. Strattera, being non-controlled, can be prescribed more freely and refilled more easily. This can improve medication adherence and reduce the hassle associated with frequent doctor visits or pharmacy restrictions. In some cases, clinicians may not be completely certain whether a patient's symptoms are primarily due to ADHD or another condition such as anxiety, depression, or trauma-related disorders. Since stimulants can exacerbate certain psychiatric symptoms or produce euphoria, starting with a non-stimulant like Strattera can be a safer way to assess a patient's response without clouding the diagnostic picture. If symptoms improve with Strattera, it may confirm that norepinephrine imbalance plays a role in the condition, guiding future treatment decisions. Choosing between Strattera and Adderall requires a personalized approach that considers the individual's medical history, lifestyle, comorbid conditions, and treatment preferences. While Adderall remains highly effective for many, Strattera presents a viable and often safer alternative for those with substance abuse risks, anxiety, sleep disturbances, or cardiovascular concerns. It is also a strong option for patients seeking all-day symptom coverage or those who prefer to avoid controlled substances. Consulting with a knowledgeable healthcare provider is crucial in determining which medication best aligns with the patient's needs and long-term goals. TIME BUSINESS NEWS
Time Business News
30-05-2025
- Health
- Time Business News
Patient Testimonials: Choosing Strattera Over Adderall
When it comes to treating Attention Deficit Hyperactivity Disorder (ADHD), two commonly prescribed medications often enter the conversation: strattera vs adderall. While Adderall, a stimulant, remains a go-to option for many, a growing number of patients are sharing positive experiences after choosing Strattera, a non-stimulant alternative. In this blog, we dive deep into real patient testimonials that shed light on why some individuals are switching from Adderall to Strattera and how it has impacted their lives. When managing depression and anxiety, selecting an effective medication is crucial. Both Lexapro vs zoloft are popular selective serotonin reuptake inhibitors (SSRIs) prescribed to improve mood and reduce symptoms. While they share similarities in how they work, their differences can influence individual response and side effects. In the middle of treatment considerations, lexapro vs zoloft often arises as a common question due to their subtle variations in dosage, onset speed, and tolerability. Ultimately, a healthcare provider's guidance is essential to determine which option aligns best with a patient's unique medical history and symptom profile. For many patients, the decision to move from Adderall to Strattera is rooted in the desire for more stable and predictable symptom management. Adderall, though effective for focus and attention, has a fast-acting profile that can lead to noticeable 'ups and downs' throughout the day. Users often report a strong initial boost in energy and focus, followed by a crash or feelings of anxiety and irritability. One patient, a 34-year-old software engineer, shared his story of feeling emotionally 'on edge' while on Adderall. 'I would have these bursts of amazing focus and productivity, but by the afternoon, I'd crash hard. I was agitated, anxious, and emotionally drained.' After discussing these experiences with his psychiatrist, he was prescribed Strattera. 'It took a few weeks to kick in,' he said, 'but once it did, I noticed a more even emotional baseline. I don't feel like a superhero, but I feel like myself, just more grounded and focused.' A common theme among patient testimonials is the reduced experience of side effects with Strattera. Adderall, being a stimulant, can cause increased heart rate, elevated blood pressure, insomnia, and even dependency in some users. For those who are sensitive to stimulants or have a history of substance use, Strattera offers a safer alternative. A 28-year-old graduate student spoke candidly about her decision to switch medications. 'Adderall worked, but I hated how it made me feel. I couldn't sleep, I lost weight rapidly, and I felt emotionally flat. There was also this nagging fear of becoming dependent on it.' After switching to Strattera under her doctor's guidance, she noted, 'It wasn't an overnight change, but over the course of a month, I felt more balanced. I could sleep again, my appetite returned, and most importantly, I didn't feel like I was relying on a drug to feel normal.' Another powerful testimonial comes from individuals with both ADHD and coexisting anxiety disorders. While Adderall can sometimes exacerbate anxiety due to its stimulating effects, Strattera, which affects norepinephrine rather than dopamine, is less likely to worsen these symptoms and may even help manage them. One 19-year-old college student, recently diagnosed with ADHD and generalized anxiety disorder, described her experience. 'Adderall made my thoughts race. I was more productive, sure, but I was also constantly on edge.' Her psychiatrist recommended a trial of Strattera. 'It wasn't as immediately effective, but after six weeks, I felt like a new person. My anxiety wasn't spiking constantly, and I could study without that gnawing panic in the back of my mind.' Strattera's non-addictive profile and slow-release effects make it a popular choice for individuals seeking long-term treatment strategies. For some, especially parents managing their children's ADHD symptoms, this is a decisive factor. Strattera doesn't carry the same potential for abuse or misuse as Adderall, which provides peace of mind. A parent of a 12-year-old boy with ADHD shared their family's journey. 'We tried Adderall first because it's what everyone recommended. But we noticed mood swings and even mild aggression at times.' The family, in consultation with a pediatric psychiatrist, transitioned to Strattera. 'It was like night and day. No more meltdowns in the evening. He's still the same kid—just calmer, more attentive, and happier overall. We feel better knowing he's on something that's not addictive.' A significant insight from patient stories is the need for patience when starting Strattera. Unlike Adderall, which has a rapid onset, Strattera takes several weeks to reach full effectiveness. This delay can be frustrating for individuals expecting immediate results, but many say it's worth the wait. One adult with ADHD explained, 'I was skeptical at first. After years of instant results from Adderall, the idea of waiting 4-6 weeks for something to work seemed crazy.' However, after sticking with the treatment, he reported, 'The changes crept up on me. I realized one day I was more organized, less impulsive, and didn't dread my to-do list anymore. The transformation was gradual, but real.' Interestingly, some patients also mentioned that switching to a non-stimulant helped reduce the stigma they felt around taking medication for ADHD. Adderall's association with 'study drugs' or performance enhancers made some users feel self-conscious or judged. A 26-year-old marketing professional said, 'I hated the looks I'd get when people found out I was on Adderall. It felt like cheating. With Strattera, I feel like I'm taking something to treat my condition, not to give me a boost.' She added that she now experiences better clarity of thought without the emotional rollercoaster. 'It's not about being hyper-focused; it's about being able to function like a regular adult. Strattera helps me get there.' Ultimately, the overarching message in these testimonials is that medication for ADHD is not one-size-fits-all. While Adderall is incredibly effective for some, others find that it doesn't align with their mental health goals, lifestyle, or physical tolerance. Strattera offers a viable alternative—especially for those who value emotional stability, lower abuse potential, and a gradual but lasting improvement in ADHD symptoms. As one patient summarized, 'It's not about which drug is better—it's about which one is better for you. For me, that's Strattera.' Choosing between Strattera and Adderall is a deeply personal decision that should be guided by a healthcare professional. Patient testimonials provide valuable insight, but what works wonders for one person may fall short for another. That said, the growing number of individuals finding success with Strattera is a reminder that there are effective, non-stimulant options out there. If you or a loved one are struggling with ADHD and unsure about your current treatment plan, it might be worth having a conversation about Strattera with your provider. The road to focus, calm, and clarity may just begin with a different choice. TIME BUSINESS NEWS
Time Business News
13-05-2025
- Health
- Time Business News
Strattera vs Adderall in Patients with Anxiety
Anxiety and Attention Deficit Hyperactivity Disorder (ADHD) often coexist, creating unique challenges for diagnosis and treatment. Among the many medications available for managing ADHD, Strattera (atomoxetine) and Adderall (a combination of amphetamine salts) stand out as two of the most commonly prescribed. However, the choice between them becomes more nuanced when anxiety is also present. Both medications have different mechanisms of action and impact on anxiety, making the selection process critical for effective treatment. In this blog, we will explore the key differences between Strattera vs adderall, especially in the context of patients dealing with comorbid anxiety. When it comes to managing depression and anxiety, many patients are prescribed selective serotonin reuptake inhibitors (SSRIs). Two widely used options are lexapro vs zoloft. While both medications work by increasing serotonin levels in the brain, they have distinct differences. Lexapro, often considered milder, is typically prescribed for generalized anxiety and depression, while Zoloft is often favored for a broader range of conditions, including panic disorders and PTSD. Lexapro vs Zoloft: the choice between them often depends on the patient's specific symptoms, side effects, and response to the medication. Your doctor can help guide the best choice. Strattera, or atomoxetine, is a non-stimulant medication approved by the FDA for the treatment of ADHD. It works by selectively inhibiting the reuptake of norepinephrine, thereby increasing its levels in the brain. Unlike stimulants, Strattera is not considered a controlled substance and is not associated with the same potential for abuse or dependency. It is typically taken once or twice daily, with effects building up over several weeks. Because it doesn't produce the immediate 'boost' that stimulants provide, its impact on focus and attention is generally subtler and more gradual. Adderall is a central nervous system stimulant composed of amphetamine salts. It increases the levels of dopamine and norepinephrine in the brain by blocking their reuptake and increasing their release. This dual action provides a powerful and rapid improvement in attention, focus, and impulse control, often noticeable within 30 to 60 minutes. However, it also comes with a higher risk for side effects like increased heart rate, elevated blood pressure, and sleep disturbances. Adderall is a Schedule II controlled substance due to its high potential for abuse and dependence. Studies show that up to 50% of individuals with ADHD also suffer from an anxiety disorder. This comorbidity complicates treatment because stimulant medications like Adderall can sometimes exacerbate anxiety symptoms. For patients already prone to nervousness, restlessness, or panic attacks, stimulants may increase these symptoms, even while improving focus. On the other hand, untreated ADHD can contribute to increased anxiety due to struggles with productivity, forgetfulness, and organizational challenges. Therefore, choosing the right medication involves balancing the need for improved attention with the potential impact on anxiety. One of the biggest advantages of Strattera for patients with comorbid anxiety is its generally favorable profile in terms of anxiety symptoms. Because it doesn't stimulate dopamine release in the same way as Adderall, it is less likely to cause jitteriness or exacerbate anxiety. In some cases, patients report a reduction in anxiety after starting Strattera, potentially due to improved executive function and less chaotic thinking. Furthermore, since Strattera is taken consistently and builds up gradually, it provides a more stable therapeutic effect without the peaks and valleys associated with stimulant medications. Adderall is effective at reducing core ADHD symptoms but can be problematic for individuals with anxiety. The increased release of dopamine and norepinephrine often results in heightened alertness, which may feel similar to or even trigger anxiety in sensitive individuals. Some patients describe experiencing a racing heart, increased blood pressure, or a sense of unease while on Adderall. However, this is not universally true—some people with anxiety and ADHD respond very well to Adderall, especially if their anxiety is more situational or stems from poor ADHD control. The key factor is individual variability, and close monitoring is essential. When choosing between Strattera and Adderall for a patient with both ADHD and anxiety, clinicians weigh several factors. Strattera is often the first-line treatment when anxiety is a major concern, especially in children and adolescents. It avoids the risk of stimulant-induced anxiety and is easier to manage long-term from a regulatory and compliance perspective. However, its slower onset of action may frustrate patients looking for quick symptom relief. Adderall might still be chosen if the ADHD symptoms are particularly severe and impairing, and if anxiety is well-controlled through other means such as therapy or additional medication. It's also sometimes used as a trial treatment to gauge a patient's tolerance to stimulants, with the understanding that side effects like increased anxiety might necessitate a switch to a non-stimulant. Strattera's once-daily dosing and non-stimulant nature make it convenient and low-risk for patients concerned about addiction. However, some users report side effects such as fatigue, dizziness, dry mouth, and gastrointestinal discomfort. Moreover, because it can take several weeks to become effective, patients must be patient and committed to the treatment plan. Adderall's immediate efficacy is often appealing to patients seeking fast results. Many report feeling more 'awake,' focused, and motivated shortly after taking it. However, it requires careful timing to avoid insomnia and might lead to rebound effects when the medication wears off. Patients who are prone to anxiety attacks may find these fluctuations destabilizing. In some cases, doctors may consider using both medications strategically or combining them with anti-anxiety treatments. For example, a patient might take a low dose of Adderall for academic or work performance, paired with an SSRI or CBT (Cognitive Behavioral Therapy) to manage anxiety. Alternatively, non-medication strategies such as mindfulness, structured routines, and exercise can enhance the effectiveness of either medication while reducing anxiety symptoms. The most successful treatment plans are usually those that are individualized and comprehensive. Choosing between Strattera and Adderall for patients with ADHD and anxiety requires a nuanced approach. Strattera offers a non-stimulant alternative that is generally well-tolerated by anxious individuals, while Adderall delivers potent symptom relief but carries a higher risk of aggravating anxiety. The decision should be made based on a thorough clinical evaluation, patient preferences, and ongoing monitoring. Ultimately, the goal is not just to reduce ADHD symptoms, but also to support emotional well-being, reduce anxiety, and improve overall quality of life. Collaboration between patient and provider is essential to find the right balance, and often, a bit of trial and error leads to the best outcomes. TIME BUSINESS NEWS
Time Business News
08-05-2025
- Health
- Time Business News
Which is Better for Adults with ADHD: Strattera or Adderall?
Attention Deficit Hyperactivity Disorder (ADHD) is not just a childhood condition; it affects millions of adults worldwide, impacting their ability to focus, manage time, stay organized, and complete tasks. When it comes to treatment, medication often plays a central role. Two commonly prescribed medications for adults with ADHD are strattera vs adderall. Each of these drugs works differently and carries unique benefits and risks. This article will compare Strattera and Adderall to help you understand which may be a better choice for adults managing ADHD. When it comes to treating anxiety and depression, patients often face the decision between different medications. Among the most commonly prescribed are lexapro vs zoloft, both selective serotonin reuptake inhibitors (SSRIs). While Lexapro (escitalopram) is often praised for its tolerability and simplicity with fewer drug interactions, Zoloft (sertraline) may be more suitable for certain anxiety disorders. Individual responses vary, making it important to work closely with a healthcare provider. Factors like side effects, dosage, and coexisting conditions influence the choice. Ultimately, the most effective treatment is the one tailored to the patient's unique mental health needs. ADHD in adults can manifest differently than in children. While hyperactivity may decrease with age, difficulties with attention, executive functioning, and impulsivity often persist. Many adults struggle with procrastination, forgetfulness, restlessness, and difficulty sustaining focus. These symptoms can interfere with professional responsibilities, relationships, and daily life. Treatment plans for adult ADHD often involve a combination of behavioral therapy, lifestyle adjustments, and medication. Among medications, stimulants like Adderall and non-stimulants like Strattera are the most commonly used. Adderall is a stimulant medication that contains two types of amphetamine salts: dextroamphetamine and levoamphetamine. It works by increasing the levels of dopamine and norepinephrine in the brain—neurotransmitters that play a crucial role in attention and executive function. Adderall is known for its fast-acting effects, typically beginning to work within 30 minutes to an hour of ingestion. It's available in both immediate-release (IR) and extended-release (XR) formulations, allowing flexibility in dosing and symptom management. Strattera, on the other hand, is a non-stimulant medication that contains atomoxetine. It is a selective norepinephrine reuptake inhibitor (NRI), meaning it increases norepinephrine levels in the brain without affecting dopamine to the same extent as stimulants. Unlike Adderall, Strattera doesn't provide immediate relief. It often takes several weeks to reach full effectiveness. However, its non-stimulant nature makes it a valuable alternative for individuals who can't tolerate stimulants or have a history of substance abuse. When comparing the effectiveness of Adderall and Strattera, research consistently shows that stimulants like Adderall are generally more effective at reducing core symptoms of ADHD. Adderall's impact is often more pronounced and immediate, making it a preferred first-line treatment. However, Strattera still provides significant symptom relief for many patients. Its effectiveness may be particularly noticeable in individuals with comorbid anxiety disorders, as stimulants can sometimes exacerbate anxiety symptoms. While it may take longer to see results with Strattera, it remains a viable option for those who do not respond well to stimulants. Adderall's onset of action is rapid, with effects beginning within an hour and lasting 4-6 hours for the IR form, and up to 12 hours for XR. This makes it easier for users to see immediate improvements in attention and productivity. In contrast, Strattera requires consistent daily dosing for several weeks before benefits are fully felt. It does not have the same 'on-off' effect as Adderall, providing a more stable, round-the-clock control of symptoms without noticeable peaks or crashes. Each medication comes with its own set of side effects. Adderall's side effects commonly include insomnia, loss of appetite, increased heart rate, dry mouth, and elevated blood pressure. There is also a potential for dependency, misuse, and withdrawal symptoms due to its stimulant nature. Strattera's side effects tend to be milder but may include nausea, fatigue, dizziness, mood swings, and sexual dysfunction. It does not have the same risk for abuse or dependency, making it safer for individuals with a history of substance use disorders. Both medications carry warnings about cardiovascular risks, particularly for those with pre-existing heart conditions. Additionally, both have potential psychiatric side effects, such as mood swings or increased risk of suicidal thoughts, especially in younger users. Regular monitoring and communication with a healthcare provider are essential. Choosing between Strattera and Adderall often depends on an individual's medical history, lifestyle, and personal preferences. Adderall might be the better option for those who need fast and powerful symptom relief and do not have a history of substance abuse. It is often the first choice for adults who require strong focus for work or studies. On the other hand, Strattera is better suited for adults who prefer a non-stimulant option, have co-occurring anxiety, or have conditions that make stimulant use risky. It's also ideal for those who prefer once-daily dosing without the potential highs and crashes associated with stimulants. Long-term use of Adderall requires careful oversight due to the potential for tolerance and dependence. Some users may find that the medication becomes less effective over time, requiring dosage adjustments. Strattera, with its non-stimulant profile, does not pose the same risk for addiction or tolerance, which makes it more appealing for long-term management. However, some patients may find its delayed onset and milder effects less satisfactory over the long haul. Adderall, particularly the generic versions, is generally less expensive and more widely covered by insurance than Strattera. Strattera, being a brand-name drug for a long time, has historically been more expensive, though generic atomoxetine is now available, which helps reduce the cost burden. That said, the true cost of treatment also includes factors like side effects, missed work due to unmanaged symptoms, and the time it takes to find the right medication and dosage. A cheaper medication that doesn't work well is not necessarily the more affordable option in the long run. So, which is better for adults with ADHD—Strattera or Adderall? The answer is: it depends. If you're looking for fast, effective relief and don't have contraindications for stimulant use, Adderall is typically more effective. If you have a history of substance abuse, struggle with anxiety, or are sensitive to stimulants, Strattera may be the safer and more sustainable choice. The best course of action is to work closely with a healthcare provider, ideally one experienced in treating adult ADHD. A trial-and-error approach is often necessary to find the most effective medication with the fewest side effects. In some cases, combining medication with therapy or coaching provides the best outcomes. ADHD in adults can be a challenging condition to manage, but the right medication can make a significant difference in quality of life. Both Adderall and Strattera offer unique benefits and drawbacks, and the best option depends on individual circumstances. Whether you opt for the fast-acting power of Adderall or the steady, non-stimulant support of Strattera, a thoughtful, informed approach will help you make the best decision for your mental health and productivity. TIME BUSINESS NEWS
Yahoo
11-04-2025
- Health
- Yahoo
Foster Kids Are Too Often Forced to Take Psychotropic Drugs to Manage Their Behavior
PeopleImages Stay up-to-date with the politics team. Sign up for the Teen Vogue Take I entered the foster care system at a young age, moving many times. My experience was nothing short of a nightmare. I was told that no one loved or wanted me. Without the nurturing environment and stability that a child needs to thrive, I sank deeper into hopelessness and depression, which caused me to act out. Unfortunately, instead of getting the counseling and nurturing I needed, those responsible for my care decided my behavior required multiple doses of powerful drugs, as many as five at a time. This included the antipsychotic Abilify, which made me shake involuntarily; and Strattera, a medication prescribed for ADHD, which I do not have, that has awful side effects like nausea, vomiting, dizziness, and suicidal thoughts. When you're in the foster system, it's easy to feel like you're an inconvenient problem rather than someone who deserves support and love. Far too often, as I experienced, if a kid is acting out or causing trouble, the response is psychotropic drugs — medications used to control behavior rather than address the underlying trauma a kid is living with. I was shuffled between different homes and facilities where psychotropic drugs were the norm. Rarely was I asked how I was feeling, what people could do to help, or if I wanted to take the medication. Instead, these powerful drugs were given to me as a cure-all — and without proper supervision or meaningful evaluation. To make matters worse, the effects of these medications are not temporary; I still deal with related health problems, along with enduring feelings of loneliness and isolation. An estimated 26% of youth take at least one psychotropic drug while in the foster system, according to Children's Rights, a nonprofit aimed at protecting children's civil rights and keeping families together. According to the organization, these drugs are often administered without proper informed consent prior to their use. Psychotropic drugs do have a place in treating mental health issues, but they should only be administered after the necessary protections and oversight are put in place to ensure it is a safe option for the child, with approval from the child, their caregiver, and a medical professional. The reality is that most youth in foster systems are not consulted about their own treatments, forcing them to bear the related physical and emotional trauma for years — or a lifetime. We cannot allow this to continue. I was a named plaintiff in an historic class action lawsuit in Missouri that now ensures children in the state's foster system are only administered psychotropic drugs when it is safe and necessary. This legal victory sets an example I hope other states will follow. Those in charge of state foster systems can begin by limiting the use of psychotropic drugs to situations where it's truly necessary. Rather than prescribing a pill to keep us quiet, these leaders must listen to us and invest in systems that prioritize the mental health and emotional well-being of children. Young people in systems need trauma-informed care, therapy, and stable environments to provide them with a safe space to heal. I lost my innocence and my childhood to the foster system, but I will not let this be the end of my story. I will continue fighting so others do not suffer like I did. By sharing my experience, I hope to spark a much-needed conversation about overmedication and abuse in the foster system and the urgent need for change. Originally Appeared on Teen Vogue Want more U.S. government coverage? The Current Supreme Court Is Illegitimate What It's Like to Live In a State Run By Politicians You Can't Stand Mass Incarceration Is Cruel, Expensive, and Ineffective The True Story of a White Supremacist Insurrection in the U.S.
